• Allen KJ, Cheah DM, Lee XL, Pettigrew-Buck NE, Vadolas J, Mercer JF, Ioannou PA, Williamson R 2004 The potential of bone marrow stem cells to correct liver dysfunction in a mouse model of Wilson's disease. Cell Transplant. 13: 765-773.

• Allen KJ, Cheah DM, Wright PF, Gazeas S, Pettigrew-Buck NE, Deal YH, Mercer JF, Williamson R 2004 Liver cell transplantation leads to repopulation and functional correction in a mouse model of Wilson's disease. J. Gastroenterol. Hepatol. 19: 1283-1290. *

• Aoki T, Umehara Y, Ferraresso C, Sugiyama N, Middleton Y, Avital I, Inderbitzin D, Demetriou AA, Rozga J 2002 Intrasplenic transplantation of encapsulated cells: a novel approach to cell therapy. Cell Transplant. 11: 553-561.

• Benten D, Follenzi A, Bhargava KK, Kumaran V, Palestro CJ, Gupta S 2005 Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice. Hepatology 42: 140-148. *

• Beytout J, Tournilhac O, Laurichesse H 2003 Asplenia and hyposplenism. Presse Med. 32: S5-S9.

• Bissig KD, Le TT, Woods NB, Verma IM 2007 Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc. Natl. Acad. Sci. U.S.A. 104: 20507-20511. *

• Brigden ML 2001 Detection, education and management of the asplenic or hyposplenic patient. Am. Fam. Physician 63: 499-506, 508. *

• Brigden ML, Pattullo A, Brown G 2001 Practising physician's knowledge and patterns of practice regarding the asplenic state: the need for improved education and a practical checklist. Can. J. Surg. 44: 210-216.

• Cantz T, Sharma AD, Jochheim-Richter A, Arseniev L, Klein C, Manns MP, Ott M 2004 Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration. Cell Transplant. 13: 659-666.

• Castagnola E, Fioredda F 2003 Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes. Eur. J. Haematol. 71: 319-326. *

• Castellino G, Govoni M, Prandini N, Limpido G, Bernardi S, Campione D, Lanza F, Trotta F 2007 Thrombocytosis in systemic lupus erythematosus: a possible clue to autosplenectomy? J. Rheumatol. 34: 1497-1501.

• Cornelis T, Hiele M, Vermeire S, Libbrecht L, Verslype C 2008 A unique combination of celiac disease, mesenteric lymph node cavitation, splenic atrophy and necrotizing hepatitis. Acta Gastroenterol. Belg. 71: 267-270.

• Curti A, Pandolfi S, Valzasina B, Aluigi M, Isidori A, Ferri E, Salvestrini V, Bonanno G, Rutella S, Durelli I, Horenstein AL, Fiore F, Massaia M, Colombo MP, Baccarani M, Lemoli RM 2007 Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Blood 109: 2871-2877. *

• Di Campli C, Gasbarrini G, Gasbarrini A 2003 Review article: a medicine based on cell transplantation - is there a future for treating liver diseases? Aliment. Pharmacol. Ther. 18: 473-480. *

• Di Sabatino A, Rosado MM, Cazzola P, Riboni R, Biagi F, Carsetti R, Corazza GR 2006 Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease. Clin. Gastroenterol. Hepatol. 4: 179-186.

• Di Sabatino A, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Corazza GR, Carsetti R 2005 Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am. J. Gastroenterol. 100: 1788-1795. *

• Doll DC, List AF, Yarbro JW 1987 Functional hyposplenism. South. Med. J. 80: 999-1006.

• Dray X, Joly F, Lavergne-Slove A, Treton X, Bouhnik Y, Messing B 2006 A severe but reversible refractory sprue. Gut 55: 1210-1211. *

• Dunn TB, Kumins NH, Raofi V, Holman DM, Mihalov M, Blanchard J, Law WR, Rastellini C, Benedetti E 2000 Multiple intrasplenic hepatocyte transplantations in the dalmatian dog. Surgery 127: 193-199. *

• Gupta S, Yerneni PR, Vemuru RP, Lee CD, Yellin EL, Bhargava KK 1993 Studies on the safety of intrasplenic hepatocyte transplantation: relevance to ex vivo gene therapy and liver repopulation in acute hepatic failure. Hum. Gene Ther. 4: 249-257.

• Halfdanarson TR, Litzow MR, Murray JA 2007 Hematological manifestations of celiac disease. Blood 109: 412-421. *

• Harimoto N, Taketomi A, Kitagawa D, Kuroda Y, Itoh S, Giona T, Tanaka S, Shirabe K, Shimada M, Maehara Y 2005 The newly established human hepatocyte cell line: application for the bioartificial liver. J. Hepatol. 42: 557-564. *

• Ho SH, Lee HJ, Kim DS, Jeong JG, Kim S, Yu SS, Jin Z, Kim S, Kim JM 2006 Intrasplenic electro-transfer of IL-4 encoding plasmid DNA efficiently inhibits rat experimental allergic encephalomyelitis. Biochem. Biophys. Res. Commun. 343: 816-824. *

• Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, Yang VW, Lee OK 2008 Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134: 2111-2121, e1-e3. *

• Lehmberg K, Steinhausen B, Janka G 2007 From neonates to adolescents - the diagnostic significance of pitted erythrocytes in hyposplenic and asplenic children. Klin. Padiatr. 219: 339-342.

• Ludvigsson JF, Olen O, Bell M, Ekbom A, Montgomery SM 2008 Coeliac disease and risk of sepsis. Gut 57: 1074-1080.

• Maehlen J, Heger B, Rostrup M 1997 Splenic atrophy and fatal pneumococcal infection in inflammatory bowel disease. Tidsskr. Nor. Laegeforen. 117: 1900-1901.

• Malhi H, Irani AN, Volenberg I, Schilsky ML, Gupta S 2002 Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease. Gastroenterology 122: 438-447. *

• Melles DC, de Marie S 2004 Prevention of infections in hyposplenic and asplenic patients: an update. Neth. J. Med. 62: 45-52. *

• Mendez-Uriburu L, Ahualli J, Fajre L, Ortiz Mayor M 2006 Cavitating mesenteric lymph node syndrome. Radiologia 48: 241-244.

• Merle U, Enckea J, Tuma S, Volkmann M, Naldini L, Stremmel W 2006 Lentiviral gene transfer ameliorates disease progression in Long-Evans cinnamon rats: an animal model for Wilson disease. Scand. J. Gastroenterol. 41: 974-982. *

• Miele L, Pierconti F, Forgione A, Vero V, Cammarota G, Molinari F, Masselli G, Capristo E, Martini M, Larocca LM, Civello IM, Gasbarrini G, Grieco A 2007 Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. Eur. J. Gastroenterol. Hepatol. 19: 1026-1030.

• Mikula M, Fuchs E, Huber H, Beug H, Schulte-Hermann R, Mikulits W 2004 Immortalized p19ARF null hepatocytes restore liver injury and generate hepatic progenitors after transplantation. Hepatology 39: 628-634. *

• Miyazaki M, Hardjo M, Masaka T, Tomiyama K, Mahmut N, Medina RJ, Niida A, Sonegawa H, Du G, Yong R, Takaishi M, Sakaguchi M, Huh NH 2007 Isolation of a bone marrow-derived stem cell line with high proliferation potential and its application for preventing acute fatal liver failure. Stem Cells 25: 2855-2863.

• Muller AF, Cornford E, Toghill PJ 1993 Splenic function in inflammatory bowel disease: assessment by differential interference microscopy and splenic ultrasound. Q. J. Med. 86: 333-340.

• Nowak G, Ericzon BG, Nava S, Jaksch M, Westgren M, Sumitran-Holgersson S 2005 Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo. Gut 54: 972-979. *

• Ou HY, Huang TL, Chen TY, Tsang LL, Concejero AM, Chen CL, Cheng YF 2005 Emergency splenic arterial embolization for massive variceal bleeding in liver recipient with left-sided portal hypertension. Liver Transpl. 11: 1136-1139. *

• Paine P, Hobday C, Keating JJ, Brown CM, Morris JA 2001 Ulcerative pan-colitis and primary sclerosing cholangitis with hyposplenism complicated by fatal pneumococcal meningitis. CME Gastroenterology 4: 95-96. *

• Palmer KR, Duerden BI, Holdsworth CD 1980 Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery. Gut 21: 851-854. *

• Palmer KR, Sherriff SB, Holdsworth CD, Ryan FP 1981 Further experience of hyposplenism in inflammatory bowel disease. Q. J. Med. 50: 463-471.

• Parmiani G 2005 Regression of established liver tumor induced by monoepitopic peptide-based immunotherapy. J. Hepatol. 43: 369-370.

• Pollak U, Bar-Sever Z, Hoffer V, Marcus N, Scheuerman O, Garty BZ 2008 Asplenia and functional hyposplenism in autoimmune polyglandular syndrome type 1. Eur. J. Pediatr. May 22 [Epub ahead of print].

• Rao VK, Straus SE 2006 Causes and consequences of the autoimmune lymphoproliferative syndrome. Hematology 11: 15-23.

• Ryan FP, Jones JV, Wright JK, Holdsworth CD 1981 Impaired immunity in patients with inflammatory bowel disease and hyposplenism: the response to intravenous phi X174. Gut 22: 187-189. *

• Ryan FP, Smart RC, Holdsworth CD, Preston FE 1978 Hyposplenism in inflammatory bowel disease. Gut 19: 50-55. *

• Ryan FP, Ward AM, Holdsworth CD 1991 Autoimmunity, inflammatory bowel disease and hyposplenism. Q. J. Med. 78: 59-63.

• Schiedermaier P 2004 Splanchnic hemodynamics: cirrhotic versus non-cirrhotic portal hypertension. J. Gastroenterol. Hepatol. 19: S150-S154. *

• Smart RC, Ryan FP, Holdworth CD, Preston FE 1978 Relationship between splenic size and splenic function. Gut 19: 56-59. *

• van der Bilt JD, Kranenburg O, Nijkamp MW, Smakman N, Veenendaal LM, Te Velde EA, Voest EE, van Diest PJ, Borel Rinkes IH 2005 Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 42: 165-175. *

• William BM, Corazza GR 2007 Hyposplenism: a comprehensive review. Part I: Basic concepts and causes. Hematology 12: 1-13.

Number of references = 50

www psc-literature.org